Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
Authors
Keywords
-
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 111, Issue -, Pages 109130
Publisher
Elsevier BV
Online
2022-08-12
DOI
10.1016/j.intimp.2022.109130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients
- (2022) Dmitri Guz et al. ACTA HAEMATOLOGICA
- TLR8 / TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins
- (2022) Martina Fejtkova et al. AMERICAN JOURNAL OF HEMATOLOGY
- IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
- (2022) Tadamitsu Kishimoto et al. Annual Review of Immunology
- Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes
- (2022) Monia Porpora et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- P096 Store-Operated Calcium Entry Controls Innate and Adaptive Immune Cell Function in Inflammatory Bowel Disease
- (2022) M Letizia et al. Journal of Crohns & Colitis
- Identification of gene expression profiles associated with an increased risk of post-operative recurrence in Crohn’s disease
- (2022) Marjolaine Ngollo et al. Journal of Crohns & Colitis
- Systemic sclerosis in adults. Part I: Clinical features and pathogenesis
- (2022) Rebekka Jerjen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4+ T cells and is defective in Crohn´s disease patients
- (2022) Jonas Ahlers et al. Mucosal Immunology
- Gastroparesis in systemic sclerosis: a detailed analysis using whole-gut scintigraphy
- (2022) Brittany Adler et al. RHEUMATOLOGY
- Tofacitinib and metformin reduce the dermal thickness and fibrosis in mouse model of systemic sclerosis
- (2022) Ahmet Karatas et al. Scientific Reports
- Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis
- (2022) Maria Lorena et al. Journal of Clinical Medicine
- Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6
- (2022) Andrew W. Chung et al. npj Breast Cancer
- Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis
- (2022) Anibal Méndez‑Clemente et al. ONCOLOGY REPORTS
- Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease
- (2021) Stefan Schreiber et al. GASTROENTEROLOGY
- Characterization and Function of Tumor Necrosis Factor alpha and Interleukin‐6‐Induced Osteoclasts in Rheumatoid Arthritis
- (2021) Kazuhiro Yokota et al. Arthritis & Rheumatology
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
- (2021) Dongsheng Wang et al. Frontiers of Medicine
- The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder
- (2021) Zhila Maghbooli et al. BMC Neurology
- Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
- (2021) Tomaž Omerzu et al. WIENER KLINISCHE WOCHENSCHRIFT
- A protective role for autophagy in vitiligo
- (2021) Emanuela Bastonini et al. Cell Death & Disease
- S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils
- (2021) Adéla Navrátilová et al. Scientific Reports
- Autoimmunity in vitiligo: Therapeutic implications and opportunities
- (2021) Binod K. Khaitan et al. AUTOIMMUNITY REVIEWS
- Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis
- (2021) Tsutomu Takeuchi et al. AUTOIMMUNITY REVIEWS
- Evaluation of serum interleukin-6 (IL-6), IL-13, and IL-17 levels and computed tomography finding in interstitial lung disease associated with connective tissue disease patients
- (2021) Dilek Tezcan et al. CLINICAL RHEUMATOLOGY
- Metabolic Comorbidities in Vitiligo: A Brief Review and Report of New Data from a Single-Center Experience
- (2021) Andrea D’Arino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Regulation of IL-6/STAT-3/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: Novel mechanistic insight
- (2021) Fares E.M. Ali et al. LIFE SCIENCES
- Loss of Interleukin-6 Influences Transcriptional Immune Signatures and Alters Bacterial Colonization in the Skin
- (2021) Lerin R. Luckett-Chastain et al. Frontiers in Microbiology
- Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19
- (2021) Dinah V. Parums MEDICAL SCIENCE MONITOR
- SYSTEMIC SCLEROSIS‐ASSOCIATED INTERSTITIAL LUNG DISEASE: How to incorporate two Food and Drug Administration‐approved therapies in clinical practice
- (2021) Dinesh Khanna et al. Arthritis & Rheumatology
- The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells
- (2021) Lara Magni et al. Cells
- Overexpression of Lin28a Aggravates Psoriasis-Like Phenotype by Regulating the Proliferation and Differentiation of Keratinocytes
- (2021) Soyeon Jang et al. Journal of Inflammation Research
- Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3/AUF1 pathway
- (2021) Naif Al-Jomah et al. CARCINOGENESIS
- Epigenetic drug ameliorated type 1 diabetes via decreased generation of Th1 and Th17 subsets and restoration of self-tolerance in CD4+ T cells
- (2021) Vasu Patel et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Development of type 1 diabetes in a patient treated with anti‐interleukin‐6 receptor antibody for rheumatoid arthritis
- (2021) Eiji Kawasaki et al. Journal of Diabetes Investigation
- IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
- (2021) Carla J. Greenbaum et al. JCI Insight
- Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
- (2021) Anna Campanati et al. Biomedicines
- Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial
- (2021) Xavier Mariette et al. Lancet Rheumatology
- Interferon-γ induces interleukin-6 production by neutrophils via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway
- (2021) Shuhei Yoshida et al. BMC Research Notes
- Experiences and needs of children with siblings diagnosed with Type 1 diabetes: A mixed studies systematic review
- (2021) Kathlynn Kai Ling Chan et al. Journal of Pediatric Nursing-Nursing Care of Children & Families
- Rho kinase Blockade Ameliorates DSS-Induced Ulcerative Colitis in Mice Through Dual Inhibition of the NF-κB and IL-6/STAT3 Pathways
- (2020) Yifan Wang et al. INFLAMMATION
- Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials
- (2020) Ambrish Singh et al. Modern Rheumatology
- Super Critical Fluid Extracted Fatty Acids from Withania somnifera Seeds Repair Psoriasis-Like Skin Lesions and Attenuate Pro-Inflammatory Cytokines (TNF-α and IL-6) Release
- (2020) Acharya Balkrishna et al. Biomolecules
- Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
- (2020) R. Marfella et al. DIABETES & METABOLISM
- Pathophysiology of Gastroparesis Syndromes Includes Anatomic and Physiologic Abnormalities
- (2020) Thomas L. Abell et al. DIGESTIVE DISEASES AND SCIENCES
- Translating IL-6 biology into effective treatments
- (2020) Ernest H. Choy et al. Nature Reviews Rheumatology
- Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures
- (2020) Wilma Barcellini et al. Expert Review of Hematology
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer
- (2020) Noura N. Alraouji et al. MOLECULAR CARCINOGENESIS
- IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
- (2020) Mario Stampanoni Bassi et al. Frontiers in Cellular Neuroscience
- Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
- (2020) Agnieshka M. Agasing et al. Nature Communications
- Investigation of the Role of Interleukin 6 in Vitiligo Pathogenesis
- (2020) Mala Singh et al. IMMUNOLOGICAL INVESTIGATIONS
- Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6
- (2020) Ryota Tanaka et al. Communications Biology
- Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
- (2020) Hamidreza Samaee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
- (2020) Reza Malekzadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tocilizumab inhibits IL‐8 and the proangiogenic potential of triple negative breast cancer cells
- (2020) Noura N. Alraouji et al. MOLECULAR CARCINOGENESIS
- Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
- (2020) Belén Ruiz-Antorán et al. Infectious Diseases and Therapy
- IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis
- (2019) Marina von Essen et al. Cells
- Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy
- (2019) Lara L. Riegler et al. Therapeutics and Clinical Risk Management
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- The pathogenicity of Th17 cells in autoimmune diseases
- (2019) Keiko Yasuda et al. Seminars in Immunopathology
- IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis
- (2019) A. Francesca Setiadi et al. JOURNAL OF NEUROIMMUNOLOGY
- Role and mechanism of the Th17/Treg cell balance in the development and progression of insulin resistance
- (2019) Limin Tao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Role of T Follicular Helper Cells and T Follicular Regulatory Cells in the Pathogenesis of Autoimmune Hemolytic Anemia
- (2019) Yuhan Gao et al. Scientific Reports
- A potential therapeutic target RNA-binding protein, Arid5a for the treatment of inflammatory disease associated with aberrant cytokine expression
- (2018) Kazuya Masuda et al. CURRENT PHARMACEUTICAL DESIGN
- Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis
- (2018) Yvette N. Lamb et al. DRUGS
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a
- (2018) Mitsuru Higa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent Advances in Giant Cell Arteritis
- (2018) M. Guevara et al. Current Rheumatology Reports
- S100 Proteins As an Important Regulator of Macrophage Inflammation
- (2018) Chang Xia et al. Frontiers in Immunology
- IL-6 signalling pathways and the development of type 2 diabetes
- (2018) Mohamad Akbari et al. INFLAMMOPHARMACOLOGY
- MicroRNA let-7b inhibits keratinocyte differentiation by targeting IL-6 mediated ERK signaling in psoriasis
- (2018) Yan Wu et al. Cell Communication and Signaling
- Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1
- (2018) Aleksandra Maria Dufour et al. Frontiers in Immunology
- Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?
- (2018) Ali Berkant Avci et al. BIODRUGS
- MicroRNA-217 regulates interstitial pneumonia via IL-6
- (2018) Jiongwei Pan et al. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
- Molecular and functional heterogeneity of IL-10-producing CD4+ T cells
- (2018) Leonie Brockmann et al. Nature Communications
- Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner
- (2017) Lin Sun et al. Journal of Neuroinflammation
- The role of IL-6 in host defence against infections: immunobiology and clinical implications
- (2017) Stefan Rose-John et al. Nature Reviews Rheumatology
- Interleukin-6 and interleukin-17 gene polymorphism association with celiac disease in children
- (2017) Ulas Emre Akbulut et al. Turkish Journal of Gastroenterology
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
- (2017) Debomita Chakraborty et al. Nature Communications
- Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
- (2017) Steffen Riethmueller et al. PLOS BIOLOGY
- IL-6 promotes the differentiation of a subset of naive CD8 + T cells into IL-21–producing B helper CD8 + T cells
- (2016) Rui Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression
- (2016) Christian Hundhausen et al. Science Translational Medicine
- Formulary Review of 2 New Biologic Agents: Tocilizumab for Rheumatoid Arthritis and Ustekinumab for Plaque Psoriasis
- (2016) Jeremy A. Schafer et al. JOURNAL OF MANAGED CARE PHARMACY
- A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
- (2015) E. M. Dijkgraaf et al. ANNALS OF ONCOLOGY
- Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms
- (2015) Takashi Mino et al. CELL
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues
- (2015) Gareth W. Jones et al. IMMUNOLOGY
- Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis
- (2015) Haifeng Hou et al. INFLAMMATION RESEARCH
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- Clinical Development of Siltuximab
- (2015) Christine C. Davis et al. Current Oncology Reports
- Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells
- (2015) NA-HYUN KIM et al. Oncology Letters
- Siltuximab: First Global Approval
- (2014) Anthony Markham et al. DRUGS
- Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation
- (2014) Magdalena K. Poplutz et al. IMMUNOBIOLOGY
- Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
- (2014) Lanxi Song et al. Journal of Thoracic Oncology
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies
- (2014) Joanna Kitley et al. JAMA Neurology
- Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- Cutting Edge: STAT1 Is Required for IL-6-Mediated Bcl6 Induction for Early Follicular Helper Cell Differentiation
- (2013) Y. S. Choi et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
- (2013) Kazuya Masuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy
- (2013) Atsushi Kaneko Therapeutic Advances in Chronic Disease
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The biology and mechanism of action of suppressor of cytokine signaling 3
- (2012) Jeffrey J. Babon et al. GROWTH FACTORS
- A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
- (2012) Gary Hudes et al. INVESTIGATIONAL NEW DRUGS
- The origins, function, and regulation of T follicular helper cells
- (2012) Cindy S. Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-6 deficiency exacerbates skin inflammation in a murine model of irritant dermatitis
- (2012) Eric G. Lee et al. Journal of Immunotoxicology
- Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
- (2012) Shumpei Yokota et al. Therapeutic Advances in Musculoskeletal Disease
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
- (2011) Trevor J Bayliss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
- (2011) Satoru Shinriki et al. JOURNAL OF PATHOLOGY
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tocilizumab for the treatment of rheumatoid arthritis
- (2010) Toshio Tanaka et al. Expert Review of Clinical Immunology
- Tocilizumab
- (2010) Adith Venkiteshwaran mAbs
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir
- (2010) Toshio HIRANO PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
- (2009) Kenneth L. Becker et al. CRITICAL CARE MEDICINE
- Tocilizumab
- (2009) Vicki Oldfield et al. DRUGS
- Tocilizumab
- (2009) Clemens Scheinecker et al. NATURE REVIEWS DRUG DISCOVERY
- The role of Toll-like receptors in rheumatoid arthritis
- (2009) Qi-Quan Huang et al. Current Rheumatology Reports
- Tocilizumab: An lnterleukin-6 Receptor Inhibitor for the Treatment of Rheumatoid Arthritis
- (2008) Susyn L Plushner ANNALS OF PHARMACOTHERAPY
- Systematic review of the association between circulating interleukin-6 (IL-6) and cancer
- (2008) Katriina Heikkilä et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search